- Home
- EVG
EVG
Eaton Vance Short Diversified Income Fund Eaton Vance Short Duration Diversified Income Fund of Beneficial Interest
as 12-18-2024 1:36pm EST
| Founded: | 2005 | Country: | United States |
| Employees: | N/A | City: | N/A |
| Market Cap: | N/A | IPO Year: | N/A |
| Target Price: | N/A | AVG Volume (30 days): | 49.4K |
| Analyst Decision: | N/A | Number of Analysts: | N/A |
| Dividend Yield: | Dividend Payout Frequency: | Monthly | |
| EPS: | N/A | EPS Growth: | N/A |
| 52 Week Low/High: | $9.13 - $10.86 | Next Earning Date: | 01-01-0001 |
| Revenue: | N/A | Revenue Growth: | N/A |
| Revenue Growth (this year): | N/A | Revenue Growth (next year): | N/A |
Latest Eaton Vance Short Diversified Income Fund Eaton Vance Short Duration Diversified Income Fund of Beneficial Interest News
EVG Breaking Stock News: Dive into EVG Ticker-Specific Updates for Smart Investing
Associated Press Finance
a year ago
Bank7: Q4 Earnings Snapshot
Benzinga
a year ago
I Want To Add An Investment Property To My Retirement Portfolio. Should I Focus On Cash Flow Or Appreciation?
GlobeNewswire
a year ago
Viscosupplementation Market Predicted to Hit US$ 13.6 Billion in 2032, Riding on a Strong 10.8% CAGR | According to Persistence Market Research
Zacks
a year ago
Best Momentum Stocks to Buy for January 22nd
GlobeNewswire
a year ago
U.S. FDA Updates LDL-C Lowering Indication for Esperion’s NEXLETOL® (bempedoic acid) Tablet and NEXLIZET® (bempedoic acid and ezetimibe) Tablet
Zacks
a year ago
Here's What Key Metrics Tell Us About Ooma (OOMA) Q3 Earnings
Business Wire
a year ago
Aura Biosciences Announces First Patient Dosed in Global Phase 3 CoMpass Trial Evaluating the Safety and Efficacy of Belzupacap Sarotalocan (Bel-sar) for First-Line Treatment of Early-Stage Choroidal Melanoma
Business Wire
a year ago
Distribution Dates and Amounts Announced for Certain BlackRock Closed-End Funds
Compare EVG vs Leading Stocks
Share on Social Networks:
Disclaimer
The information presented on this page, "EVG Eaton Vance Short Diversified Income Fund Eaton Vance Short Duration Diversified Income Fund of Beneficial Interest - Stocks Price | History | Analysis", including historical data, forecasts, news, insider information, and predictions, is provided for educational purposes only. It should not be considered as financial advice or a recommendation to buy or sell any securities. Decisions regarding investments should be made only after careful consideration and consultation with a qualified financial advisor. We do not endorse or guarantee the accuracy or reliability of the information provided, and we disclaim any liability for financial losses incurred as a result of decisions made based on the information presented.